2-(morpholin-4-yl)-1,7-naphthyridines

The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...

Full description

Saved in:
Bibliographic Details
Main Authors Briem, Hans, Eberspächer, Uwe, Von Nussbaum, Franz, Moosmayer, Dieter, Siemeister, Gerhard, Grudzinska-Goebel, Joanna, Lefranc, Julien, Bader, Benjamin, Lienau, Philip, Lücking, Ulrich, Wortmann, Lars, Koppitz, Marcus, Wengner, Antje Margret, Schick, Hans, Eis, Knut, Bone, Wilhelm
Format Patent
LanguageEnglish
Published 15.09.2020
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
AbstractList The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
Author Siemeister, Gerhard
Bone, Wilhelm
Lienau, Philip
Lücking, Ulrich
Briem, Hans
Bader, Benjamin
Lefranc, Julien
Eis, Knut
Schick, Hans
Wortmann, Lars
Wengner, Antje Margret
Eberspächer, Uwe
Koppitz, Marcus
Grudzinska-Goebel, Joanna
Moosmayer, Dieter
Von Nussbaum, Franz
Author_xml – fullname: Briem, Hans
– fullname: Eberspächer, Uwe
– fullname: Von Nussbaum, Franz
– fullname: Moosmayer, Dieter
– fullname: Siemeister, Gerhard
– fullname: Grudzinska-Goebel, Joanna
– fullname: Lefranc, Julien
– fullname: Bader, Benjamin
– fullname: Lienau, Philip
– fullname: Lücking, Ulrich
– fullname: Wortmann, Lars
– fullname: Koppitz, Marcus
– fullname: Wengner, Antje Margret
– fullname: Schick, Hans
– fullname: Eis, Knut
– fullname: Bone, Wilhelm
BookMark eNrjYmDJy89L5WRQNdLVyM0vKsjIz8nM0zXRrczR1DXUMdfNSyzIKMmoLMpMycxLLeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYYG5uZGFpbGTkbGxKgBAJROJ9s
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US10772893B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10772893B23
IEDL.DBID EVB
IngestDate Fri Sep 20 10:13:54 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10772893B23
Notes Application Number: US201815974536
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200915&DB=EPODOC&CC=US&NR=10772893B2
ParticipantIDs epo_espacenet_US10772893B2
PublicationCentury 2000
PublicationDate 20200915
PublicationDateYYYYMMDD 2020-09-15
PublicationDate_xml – month: 09
  year: 2020
  text: 20200915
  day: 15
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies BAYER PHARMA AKTIENGESELLSCHAFT
RelatedCompanies_xml – name: BAYER PHARMA AKTIENGESELLSCHAFT
Score 3.286452
Snippet The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title 2-(morpholin-4-yl)-1,7-naphthyridines
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200915&DB=EPODOC&locale=&CC=US&NR=10772893B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUhMs0hOTDXVTTIzTtM1SUlO1bVMNDXUTQEmJiNgRjdMTAbN6Pr6mXmEmnhFmEYwMWTB9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGDTUb2iq5uJk6xrg7-LvrObsbBsarOYXBLpb1RzYtzB2AhbXrMBmtDkoN7iGOYF2pRQgVyluggxsAUDT8kqEGJhS84QZOJ1hN68JM3D4Qie8gUxo3isWYVA10tXIzQcGC-iaHV0T3cocTV1DHXPdvMSCDGBoF2WmgFawizIourmGOHvoAu2Lh3suPjQY4TRjMQYWYKc_VYJBwcIg1TLRGHQ8mBGwC2SUYmGQZArsKqQlm5ukGRpbmEoySOE2RwqfpDQDFyigQGseDE1lGFhKikpTZYEVa0mSHDhEAJGfewo
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYrOO2hRMNhb1u6hCL1Rde2G62RvpVecaFe2ivjvPSmd80XfQgK5HPKd5EvOBeCCDzM1DlNKoq6UETmJU9ILqUAS3EwiAl0IY_aj63pdZyw_TOikAa9LX5gqTuhnFRwRERUj3stKXxerRyyzsq1c3EZTrJrd2b5mcjU7Zk_9AuVMXbOGA3NgcIahjUec98RyqyrILSQd1fUaXrEVhgbrWWdeKcXvI8XegvUh9paX29BI8za0jGXmtTZsuPWHNxZr7C124FIkV-8zFAtLs0Nk8vV2TYQbheRh8YLSnk8TZsG-C-e25RsOwfGCn8UF49FqatIeNJH0p_twpvJpL5RYeDARKZCYqHxEkSpksSJngqTSA-j83U_nv8ZTaDm-2w_6997jIWwyoTH7B4EeQbOcf6THeMiW0UklnW-BfX39
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-%28morpholin-4-yl%29-1%2C7-naphthyridines&rft.inventor=Briem%2C+Hans&rft.inventor=Ebersp%C3%A4cher%2C+Uwe&rft.inventor=Von+Nussbaum%2C+Franz&rft.inventor=Moosmayer%2C+Dieter&rft.inventor=Siemeister%2C+Gerhard&rft.inventor=Grudzinska-Goebel%2C+Joanna&rft.inventor=Lefranc%2C+Julien&rft.inventor=Bader%2C+Benjamin&rft.inventor=Lienau%2C+Philip&rft.inventor=L%C3%BCcking%2C+Ulrich&rft.inventor=Wortmann%2C+Lars&rft.inventor=Koppitz%2C+Marcus&rft.inventor=Wengner%2C+Antje+Margret&rft.inventor=Schick%2C+Hans&rft.inventor=Eis%2C+Knut&rft.inventor=Bone%2C+Wilhelm&rft.date=2020-09-15&rft.externalDBID=B2&rft.externalDocID=US10772893B2